Literature DB >> 31630254

Macular ganglion-cell-complex layer thinning and optic nerve integrity in drug-naïve Parkinson's disease.

Jee-Young Lee1, Jeeyun Ahn2, Eun Jin Yoon3, Sohee Oh4, Yu Kyeong Kim3, Beomseok Jeon5.   

Abstract

To reveal the macular inner retinal change linked to axonal degeneration in Parkinson's disease (PD), we performed macular optical coherence tomography scan and diffusion tensor imaging of the retrobulbar optic nerve on both eyes of 36 drug-naïve PD patients. Thicknesses of inner retinal layers were automatically measured, and correlation analysis was conducted between the retinal thickness and diffusion parameters of the optic nerve. PD patients showed thinning of the inner retinal layers compared to control data. Thicknesses of the ganglion cell and inner plexiform layers were both correlated positively with fractional anisotropy and negatively with diffusivity indices of ipsilateral optic nerve (FDR-adjusted p < 0.05). This study revealed a novel in vivo connection between macular parafoveal ganglion cell change and integrity in the retrobulbar optic nerve in drug-naïve PD.

Entities:  

Keywords:  Diffusion tensor imaging; Macula; Optic nerve; Optical coherence tomography; Parkinson’s disease; Retina

Year:  2019        PMID: 31630254     DOI: 10.1007/s00702-019-02097-7

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  12 in total

1.  Visual symptoms in Parkinson's disease and Parkinson's disease dementia.

Authors:  Neil K Archibald; Mike P Clarke; Urs P Mosimann; David J Burn
Journal:  Mov Disord       Date:  2011-09-27       Impact factor: 10.338

2.  Optic nerve integrity as a visuospatial cognitive predictor in Parkinson's disease.

Authors:  Jae Jung Lee; Na-Young Shin; Yoonju Lee; Seung-Koo Lee; Young H Sohn; Phil Hyu Lee
Journal:  Parkinsonism Relat Disord       Date:  2016-07-01       Impact factor: 4.891

3.  Phosphorylated α-synuclein in the retina is a biomarker of Parkinson's disease pathology severity.

Authors:  Isabel Ortuño-Lizarán; Thomas G Beach; Geidy E Serrano; Douglas G Walker; Charles H Adler; Nicolás Cuenca
Journal:  Mov Disord       Date:  2018-05-08       Impact factor: 10.338

4.  Accelerated accumulation of retinal α-synuclein (pSer129) and tau, neuroinflammation, and autophagic dysregulation in a seeded mouse model of Parkinson's disease.

Authors:  Najiba Mammadova; Corey M Summers; Robyn D Kokemuller; Qing He; Shaowei Ding; Thierry Baron; Chenxu Yu; Rudy J Valentine; Donald S Sakaguchi; Anumantha G Kanthasamy; Justin J Greenlee; M Heather West Greenlee
Journal:  Neurobiol Dis       Date:  2018-09-12       Impact factor: 5.996

5.  Retinal thinning associates with nigral dopaminergic loss in de novo Parkinson disease.

Authors:  Jeeyun Ahn; Jee-Young Lee; Tae Wan Kim; Eun Jin Yoon; Sohee Oh; Yu Kyeong Kim; Jong-Min Kim; Se Joon Woo; Ki Woong Kim; Beomseok Jeon
Journal:  Neurology       Date:  2018-08-15       Impact factor: 9.910

Review 6.  Retinal layers in Parkinson's disease: A meta-analysis of spectral-domain optical coherence tomography studies.

Authors:  Asterios Chrysou; Nomdo M Jansonius; Teus van Laar
Journal:  Parkinsonism Relat Disord       Date:  2019-04-30       Impact factor: 4.891

7.  α-synuclein in the inner retina in parkinson disease.

Authors:  Ivan Bodis-Wollner; Piotr B Kozlowski; Sofya Glazman; Shahnaz Miri
Journal:  Ann Neurol       Date:  2014-06-13       Impact factor: 10.422

8.  Ganglion cell-inner plexiform layer thickness in patients with Parkinson disease and association with disease severity and duration.

Authors:  Esin S Sari; Rabia Koc; Alper Yazici; Gözde Sahin; Sitki S Ermis
Journal:  J Neuroophthalmol       Date:  2015-06       Impact factor: 3.042

9.  Retinal changes in Parkinson's disease and glaucoma.

Authors:  Juliane Matlach; Martin Wagner; Uwe Malzahn; Irene Schmidtmann; Frank Steigerwald; Thomas Musacchio; Jens Volkmann; Franz Grehn; Winfried Göbel; Stephan Klebe
Journal:  Parkinsonism Relat Disord       Date:  2018-06-21       Impact factor: 4.891

10.  Lateral geniculate atrophy in Parkinson's with visual hallucination: A trans-synaptic degeneration?

Authors:  Jee-Young Lee; Eun Jin Yoon; Woong Woo Lee; Yu Kyeong Kim; Jun-Young Lee; Beomseok Jeon
Journal:  Mov Disord       Date:  2016-02-05       Impact factor: 10.338

View more
  4 in total

Review 1.  Multimodal brain and retinal imaging of dopaminergic degeneration in Parkinson disease.

Authors:  Jee-Young Lee; Antonio Martin-Bastida; Ane Murueta-Goyena; Iñigo Gabilondo; Nicolás Cuenca; Paola Piccini; Beomseok Jeon
Journal:  Nat Rev Neurol       Date:  2022-02-17       Impact factor: 44.711

2.  The macular inner plexiform layer thickness as an early diagnostic indicator for Parkinson's disease.

Authors:  Xin Wang; Bin Jiao; Xiaoliang Jia; Yaqin Wang; Hui Liu; Xiangyu Zhu; Xiaoli Hao; Yuan Zhu; Bei Xu; Sizhe Zhang; Qian Xu; Junling Wang; Jifeng Guo; Xinxiang Yan; Beisha Tang; Rongchang Zhao; Lu Shen
Journal:  NPJ Parkinsons Dis       Date:  2022-05-25

Review 3.  Biomarkers of conversion to α-synucleinopathy in isolated rapid-eye-movement sleep behaviour disorder.

Authors:  Mitchell G Miglis; Charles H Adler; Elena Antelmi; Dario Arnaldi; Luca Baldelli; Bradley F Boeve; Matteo Cesari; Irene Dall'Antonia; Nico J Diederich; Kathrin Doppler; Petr Dušek; Raffaele Ferri; Jean-François Gagnon; Ziv Gan-Or; Wiebke Hermann; Birgit Högl; Michele T Hu; Alex Iranzo; Annette Janzen; Anastasia Kuzkina; Jee-Young Lee; Klaus L Leenders; Simon J G Lewis; Claudio Liguori; Jun Liu; Christine Lo; Kaylena A Ehgoetz Martens; Jiri Nepozitek; Giuseppe Plazzi; Federica Provini; Monica Puligheddu; Michal Rolinski; Jan Rusz; Ambra Stefani; Rebekah L S Summers; Dallah Yoo; Jennifer Zitser; Wolfgang H Oertel
Journal:  Lancet Neurol       Date:  2021-08       Impact factor: 44.182

4.  Foveal Remodeling of Retinal Microvasculature in Parkinson's Disease.

Authors:  Ane Murueta-Goyena; Maitane Barrenechea; Asier Erramuzpe; Sara Teijeira-Portas; Marta Pengo; Unai Ayala; David Romero-Bascones; Marian Acera; Rocío Del Pino; Juan Carlos Gómez-Esteban; Iñigo Gabilondo
Journal:  Front Neurosci       Date:  2021-07-12       Impact factor: 4.677

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.